Sanofi-Aventis Said to be Likely to Bid $18 Billion for Genzyme
Census Data Reveal Broad Differences Among States in Rates of Uninsured
Bystander CPR – No Breaths Necessary, Studies Say
FDA Considering Changes to Risky Drug Safeguards
Americans Still Confused About Health Reform
SUBSCRIBE